Dr Akira Nakagawara was appointed as the president of Chiba Cancer Center since 2009 and as the CEO of Saga Medical Center KOSEIKAN, and President Emeritus, Chiba Cancer Center, in 2014. He presided over many international conferences like the 2nd Japan-China Symposium on Cancer Research in 2012 and the 6th International p63p73 Workshop in 2013. Dr Akira is the chairman of many International and Domestic Assignments related to Children’s Cancers like Asian Pediatric Hematology and Oncology Group (APHOG), and the Japanese Neuroblastoma Study Group (JNBSG). He is also an Executive Core Member of the Integrative International Neuroblastoma Risk Group (iINRG) since 2012, and an International Associate Member of the Children’s Oncology Group (COG) since 2013. Dr Nakagawara is an editorial board member of many journals including Pediatric Blood & Cancer, Journal of Pediatric Surgical Specialties, Cancer Research, and Cancer Medicine. He has received many prizes for his medical achievements; among those were the JNTO National Conference Prize in 2011 and The Japan Cancer Society Prize in 2013. He has over 360 publications in the English language.